| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer
|
Sridhar, Srikala S.
|
|
2010
|
67 |
4 |
p. 927-933
|
artikel
|
| 2 |
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
|
Tolcher, Anthony W.
|
|
2010
|
67 |
4 |
p. 751-764
|
artikel
|
| 3 |
A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors
|
Yan, Zhao
|
|
2010
|
67 |
4 |
p. 955-961
|
artikel
|
| 4 |
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer
|
Arnoletti, J. P.
|
|
2010
|
67 |
4 |
p. 891-897
|
artikel
|
| 5 |
BACPTDP: a water-soluble camptothecin pro-drug with enhanced activity in hypoxic/acidic tumors
|
Adams, David J.
|
|
2010
|
67 |
4 |
p. 855-865
|
artikel
|
| 6 |
Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis
|
Chen, Wenxing
|
|
2010
|
67 |
4 |
p. 799-808
|
artikel
|
| 7 |
Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder
|
Vandepitte, Joachim
|
|
2010
|
67 |
4 |
p. 775-781
|
artikel
|
| 8 |
Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin
|
Effenberger-Neidnicht, Katharina
|
|
2010
|
67 |
4 |
p. 867-874
|
artikel
|
| 9 |
Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladder
|
Macedo, Francisco Y. B.
|
|
2010
|
67 |
4 |
p. 935-943
|
artikel
|
| 10 |
2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion
|
Xi, Haibin
|
|
2010
|
67 |
4 |
p. 899-910
|
artikel
|
| 11 |
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia
|
Helbig, Grzegorz
|
|
2011
|
67 |
4 |
p. 967-969
|
artikel
|
| 12 |
Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure
|
Radeski, Dejan
|
|
2010
|
67 |
4 |
p. 765-768
|
artikel
|
| 13 |
Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells
|
Dönmez, Yaprak
|
|
2010
|
67 |
4 |
p. 823-828
|
artikel
|
| 14 |
Imatinib mesylate enhances the malignant behavior of human breast carcinoma cells
|
Rappa, Germana
|
|
2010
|
67 |
4 |
p. 919-926
|
artikel
|
| 15 |
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer
|
Dandamudi, Uday B.
|
|
2010
|
67 |
4 |
p. 783-790
|
artikel
|
| 16 |
Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy
|
Bebb, Gwyn
|
|
2010
|
67 |
4 |
p. 837-845
|
artikel
|
| 17 |
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer
|
Oki, Yasunari
|
|
2010
|
67 |
4 |
p. 791-797
|
artikel
|
| 18 |
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
|
Dees, E. Claire
|
|
2010
|
67 |
4 |
p. 945-954
|
artikel
|
| 19 |
Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates
|
Baxter, P. A.
|
|
2010
|
67 |
4 |
p. 809-812
|
artikel
|
| 20 |
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer
|
Bonate, Peter L.
|
|
2010
|
67 |
4 |
p. 875-890
|
artikel
|
| 21 |
Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP
|
DiJoseph, John F.
|
|
2010
|
67 |
4 |
p. 741-749
|
artikel
|
| 22 |
Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
|
Masuda, Hiroko
|
|
2010
|
67 |
4 |
p. 911-917
|
artikel
|
| 23 |
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy
|
Sasaki, Takashi
|
|
2010
|
67 |
4 |
p. 847-853
|
artikel
|
| 24 |
Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect
|
Garg, Madhu B.
|
|
2010
|
67 |
4 |
p. 963-966
|
artikel
|
| 25 |
Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract
|
Cho, Kang Su
|
|
2010
|
67 |
4 |
p. 769-774
|
artikel
|
| 26 |
Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin
|
Ueda, Yutaka
|
|
2010
|
67 |
4 |
p. 829-835
|
artikel
|
| 27 |
Solamargine, a steroidal alkaloid glycoside, induces oncosis in human K562 leukemia and squamous cell carcinoma KB cells
|
Sun, Lingmei
|
|
2010
|
67 |
4 |
p. 813-821
|
artikel
|
| 28 |
Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers
|
Shimoyama, Shouji
|
|
2011
|
67 |
4 |
p. 729-739
|
artikel
|
Tijdschrift beschrijving